Cargando…
Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733395/ https://www.ncbi.nlm.nih.gov/pubmed/31564822 http://dx.doi.org/10.2147/OPTH.S223496 |
_version_ | 1783449977821855744 |
---|---|
author | Stock, Ricardo Alexandre Röhrig, Mariéli Wobeto Mezzomo, Camila Duranti Bonamigo, Elcio Luiz |
author_facet | Stock, Ricardo Alexandre Röhrig, Mariéli Wobeto Mezzomo, Camila Duranti Bonamigo, Elcio Luiz |
author_sort | Stock, Ricardo Alexandre |
collection | PubMed |
description | PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after the proposed treatments; and to identify potential complications associated with phacoemulsification. PATIENTS AND METHODS: This retrospective observational study evaluated 22 eyes of 12 patients between September 2006 and September 2018, with a minimum follow-up period of 9 months. RESULTS: After iridotomy, a persistent increase in intraocular pressure was observed in 42.85% of the cases, 100% of the patients required antiglaucoma medications, and recurrence of angle closure was observed in 28.57% of the cases. In contrast, during follow-up of phacoemulsification, the intraocular pressure levels in all eyes evaluated remained normal, without the need for medication, and no recurrence of the glaucomatous crisis or other complications was observed. CONCLUSION: Phacoemulsification maybe consequently more effective than laser iridotomy for the resolution of angle-closure glaucoma and particularly for preventing its relapses. |
format | Online Article Text |
id | pubmed-6733395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67333952019-09-27 Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis Stock, Ricardo Alexandre Röhrig, Mariéli Wobeto Mezzomo, Camila Duranti Bonamigo, Elcio Luiz Clin Ophthalmol Original Research PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after the proposed treatments; and to identify potential complications associated with phacoemulsification. PATIENTS AND METHODS: This retrospective observational study evaluated 22 eyes of 12 patients between September 2006 and September 2018, with a minimum follow-up period of 9 months. RESULTS: After iridotomy, a persistent increase in intraocular pressure was observed in 42.85% of the cases, 100% of the patients required antiglaucoma medications, and recurrence of angle closure was observed in 28.57% of the cases. In contrast, during follow-up of phacoemulsification, the intraocular pressure levels in all eyes evaluated remained normal, without the need for medication, and no recurrence of the glaucomatous crisis or other complications was observed. CONCLUSION: Phacoemulsification maybe consequently more effective than laser iridotomy for the resolution of angle-closure glaucoma and particularly for preventing its relapses. Dove 2019-09-05 /pmc/articles/PMC6733395/ /pubmed/31564822 http://dx.doi.org/10.2147/OPTH.S223496 Text en © 2019 Stock et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Stock, Ricardo Alexandre Röhrig, Mariéli Wobeto Mezzomo, Camila Duranti Bonamigo, Elcio Luiz Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title | Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title_full | Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title_fullStr | Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title_full_unstemmed | Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title_short | Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
title_sort | phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733395/ https://www.ncbi.nlm.nih.gov/pubmed/31564822 http://dx.doi.org/10.2147/OPTH.S223496 |
work_keys_str_mv | AT stockricardoalexandre phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis AT rohrigmarieliwobeto phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis AT mezzomocamiladuranti phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis AT bonamigoelcioluiz phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis |